4//SEC Filing
Martin James Joseph 4
Accession 0001493152-20-011718
CIK 0001412486other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:05 PM ET
Size
5.8 KB
Accession
0001493152-20-011718
Insider Transaction Report
Form 4
Martin James Joseph
Co-CEO and CFO
Transactions
- Award
Stock Options (Right to Buy)
2020-06-22+150,000→ 150,000 totalExercise: $1.33Exp: 2030-06-22→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]The stock options are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code.
- [F2]The stock options vest as follows: 75,000 stock options will vest on the one year anniversary of the grant date and the remaining 75,000 stock options will vest in eight equal quarterly increments with the first such quarterly increment vesting on September 30, 2021.
Documents
Issuer
Cocrystal Pharma, Inc.
CIK 0001412486
Entity typeother
Related Parties
1- filerCIK 0001510224
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 4:05 PM ET
- Size
- 5.8 KB